Table 3.
% 1-Year ACGL1 | % 3-Year ACGL | % 5-Year ACGL | |
---|---|---|---|
Living Donor KT | |||
No Impairment | 2.4 (1.2–4.7) | 7.6 (5.0–11.5) | 10.6 (7.1–15.7) |
Cognitive Impairment | 8.7 (2.3–30.5) | 18.3 (7.3–41.8) | 45.5 (20.3–80.4) |
No Severe Impairment | 2.6 (1.4–4.9) | 8.0 (5.4–11.9) | 11.6 (7.9–16.9) |
Severe Impairment | 8.3 (1.2–46.1) | 16.7 (4.5–51.8) | 37.5 (11.8–82.8) |
Deceased Donor KT | |||
No Impairment | 6.3 (4.3–9.0) | 17.7 (13.4–22.6) | 24.9 (19.6–31.3) |
Cognitive Impairment | 9.7 (4.5–20.3) | 18.6 (10.3–32.3) | 26.8 (15.3–44.5) |
No Severe Impairment | 6.5 (4.6–9.0) | 17.3 (13.6–21.8) | 24.2 (19.3–30.2) |
Severe Impairment | 15.4 (4.1–48.8) | 37.3 (15.3–73.3) | 53.0 (24.5–86.8) |
ACGL estimated by the Kaplan-Meier method with 95% confidence intervals shown in parentheses.